1. miR-448 is a novel prognostic factor of lung squamous cell carcinoma and regulates cells growth and metastasis by targeting DCLK1
   Changting Shan et al, 2017, Biomedicine & Pharmacotherapy CrossRef
2. MicroRNA-1288 promotes cell proliferation of human glioblastoma cells by repressing ubiquitin carboxyl-terminal hydrolase CYLD expression
   Jun Yin et al, 2017 CrossRef
3. MicroRNA-448 suppresses metastasis of pancreatic ductal adenocarcinoma through targeting JAK1/STAT3 pathway
   Dan-Li Yu et al, 2017 CrossRef
4. An Enrichment Strategy Yields Seven Novel Single Nucleotide Polymorphisms Associated With Mortality and Altered Th17 Responses Following Blunt Trauma
   Lukas Schimunek et al, 2018, SHOCK CrossRef
5. Downregulation of microRNA-448 inhibits IL-1β-induced cartilage degradation in human chondrocytes via upregulation of matrilin-3
   Hao Yang et al, 2018, Cell Mol Biol Lett CrossRef
6. The Long Non-Coding RNA RP5-1024C24.1 and Its Associated-Gene MPPED2 Are Down-Regulated in Human Thyroid Neoplasias and Act as Tumour Suppressors
   Romina Sepe et al, 2018, Cancers CrossRef
7. LncRNA PRNCR1 interacts with HEY2 to abolish miR-448-mediated growth inhibition in non-small cell lung cancer
   Dezhi Cheng et al, 2018, Biomedicine & Pharmacotherapy CrossRef
8. miRNA-448 inhibits cell growth by targeting BCL-2 in hepatocellular carcinoma
   Zhi-bin Liao et al, 2018, Digestive and Liver Disease CrossRef
9. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer
   Simeng Gu et al, 2019, Clin Epigenet CrossRef
10. Effect of glycolysis inhibition by miR-448 on glioma radiosensitivity
    Fengming Lan et al, 2019 CrossRef
11. The Metallophosphoesterase-Domain-Containing Protein 2 (MPPED2) Gene Acts as Tumor Suppressor in Breast Cancer
    Simona Pellecchia et al, 2019, Cancers CrossRef
12. MicroRNA-448 suppresses osteosarcoma cell proliferation and invasion through targeting EPHA7.
    Xiangkun Wu et al, 2017, PLoS One CrossRef
13. MPPED2 Polymorphism Is Associated With Altered Systemic Inflammation and Adverse Trauma Outcomes
    Lukas Schimunek et al, 2019, Front. Genet. CrossRef
14. MicroRNA-448 targets SATB1 to reverse the cisplatin resistance in lung cancer via mediating Wnt/β-catenin signalling pathway
    Mei-Ying Ning et al, 2020 CrossRef
15. MiR-448 targets BLC2 and inhibits the growth of pituitary adenoma cells
    Chao He et al, 2020, Biochem. Cell Biol. CrossRef
16. MicroRNA‑342‑3p functions as a tumor suppressor by targeting LIM and SH3 protein 1 in oral squamous cell carcinoma
    Xiaoyan Song et al, 2018, Oncol Lett CrossRef
17. Tumor expression of miR-448 is a prognostic marker in oral squamous cell carcinoma
    Hui Wei et al, 2020, BMC Cancer CrossRef
18. MiR-524 suppressed the progression of oral squamous cell carcinoma by suppressing Metadherin and NF-κB signaling pathway in OSCC cell lines
    Xiang-shuang Chang et al, 2021, Archives of Oral Biology CrossRef
19. MPPED2 is downregulated in glioblastoma, and its restoration inhibits proliferation and increases the sensitivity to temozolomide of glioblastoma cells
    Simona Pellecchia et al, 2021, Cell Cycle CrossRef
20. Noncoding RNAs in Thyroid-Follicular-Cell-Derived Carcinomas
    Marco De Martino et al, 2022, Cancers CrossRef
21. Association of MPPED2 gene variant rs10767873 with kidney function and risk of cardiovascular disease in patients with hypertension
    Yixuan Zhong et al, 2023, J Hum Genet CrossRef
22. A snapshot of miRNAs in Oral Squamous Cell Carcinoma: difference between cancer cells and corresponding normal cells
    Vahid Hosseini et al, 2023, Pathology - Research and Practice CrossRef
23. MiRNA-related metastasis in oral cancer: moving and shaking
    Meghdad Eslami et al, 2023, Cancer Cell Int CrossRef